Teva Pharmaceutical sees more growth in 2025 after strong Q3 - MSN
| SHOM Stock | ILS 843.70 6.00 0.71% |
About 62% of EN Shoham's investor base is looking to short. The analysis of current outlook of investing in EN Shoham Business suggests that many traders are alarmed regarding EN Shoham's prospects. The current market sentiment, together with EN Shoham's historical and current headlines, can help investors time the market. In addition, many technical investors use EN Shoham Business stock news signals to limit their universe of possible portfolio assets.
SHOM |
Teva Pharmaceutical sees more growth in 2025 after strong Q3 MSN
Read at news.google.com
 |
EN Shoham Fundamental Analysis
We analyze EN Shoham's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of EN Shoham using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of EN Shoham based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Ratio
Current Ratio Comparative Analysis
EN Shoham is currently under evaluation in current ratio category among its peers. Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
EN Shoham Business Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with EN Shoham stock to make a market-neutral strategy. Peer analysis of EN Shoham could also be used in its relative valuation, which is a method of valuing EN Shoham by comparing valuation metrics with similar companies.
Peers
EN Shoham Related Equities
| MNIF | Menif Financial | 0.64 | ||||
| ACCL | Accel Solutions | 1.22 | ||||
| RPAC | Rapac Communication | 1.26 | ||||
| RANI | Rani Zim | 2.32 | ||||
| MISH | Mivtach Shamir | 2.33 |
Complementary Tools for SHOM Stock analysis
When running EN Shoham's price analysis, check to measure EN Shoham's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EN Shoham is operating at the current time. Most of EN Shoham's value examination focuses on studying past and present price action to predict the probability of EN Shoham's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EN Shoham's price. Additionally, you may evaluate how the addition of EN Shoham to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |